INBRAIN Neuroelectronics
INBRAIN Neuroelectronics is dedicated to developing breakthrough neuroelectronic therapies using graphene-based neural interfaces. Their mission is to decode and modulate the brain and entire neural system to improve lives through innovative, minimally invasive, and intelligent neurotechnology. Recognized as a 2025 Technology Pioneer by the World Economic Forum, INBRAIN is pioneering a new class of brain-computer interfaces to treat neurological disorders with unprecedented precision, leveraging graphene's unique properties for high-resolution, safe, scalable therapies.
Industries
Nr. of Employees
small (1-50)
INBRAIN Neuroelectronics
BALDIRI REIXAC 4 EDI CRUSTAR 2, 08028 BARCELONA, SPAIN
Products
Graphene-based high-density implantable neural interface platform (development-stage)
A platform combining flexible graphene-based microelectrodes, an implantable processing unit with wireless rechargeable power, and AI-enabled closed-loop software to decode and modulate neural circuits.
Graphene-enabled bioelectronic vagus nerve therapy development (collaborative project)
Development-stage program focusing on selective neurostimulation of the vagus nerve using graphene electrodes to enable targeted treatment of inflammatory, metabolic and endocrine disorders.
Graphene-based high-density implantable neural interface platform (development-stage)
A platform combining flexible graphene-based microelectrodes, an implantable processing unit with wireless rechargeable power, and AI-enabled closed-loop software to decode and modulate neural circuits.
Graphene-enabled bioelectronic vagus nerve therapy development (collaborative project)
Development-stage program focusing on selective neurostimulation of the vagus nerve using graphene electrodes to enable targeted treatment of inflammatory, metabolic and endocrine disorders.
Services
Research and engineering services to design high-density, graphene-enabled implantable neural interfaces and supporting software for real-time decoding and neuromodulation.
Collaborative development service to create targeted bioelectronic therapies for chronic diseases using graphene-enabled interfaces and signal processing expertise.
Advisory and operational support covering regulatory strategy, quality systems, and clinical affairs aimed at device translation and early-stage clinical evaluation.
Research and engineering services to design high-density, graphene-enabled implantable neural interfaces and supporting software for real-time decoding and neuromodulation.
Collaborative development service to create targeted bioelectronic therapies for chronic diseases using graphene-enabled interfaces and signal processing expertise.
Advisory and operational support covering regulatory strategy, quality systems, and clinical affairs aimed at device translation and early-stage clinical evaluation.
Expertise Areas
- Brain–computer interface development
- Closed-loop neuromodulation and AI-driven therapy personalization
- Graphene-based neuroelectrode materials and device engineering
- Implantable medical device hardware and embedded signal processing
Key Technologies
- Graphene-based microtransistor electrodes
- High-density microelectrode arrays
- Wireless implantable processors with rechargeable power
- AI-driven closed-loop neuromodulation algorithms
News & Updates
INBRAIN successfully performed the first human implant of a graphene-based BCI, advancing neural disorder treatments.
INBRAIN's GphT-BCI project aims to revolutionize BCIs through innovative graphene technology, in collaboration with ICN2.
INBRAIN was recognized as a 2025 Technology Pioneer by the World Economic Forum for its innovative neurotechnology.
INBRAIN successfully performed the first human implant of a graphene-based BCI, advancing neural disorder treatments.
INBRAIN's GphT-BCI project aims to revolutionize BCIs through innovative graphene technology, in collaboration with ICN2.
INBRAIN was recognized as a 2025 Technology Pioneer by the World Economic Forum for its innovative neurotechnology.